Novel Monoclonal Antibodies Against Thymidine Kinase 1 and Their Potential Use for the Immunotargeting of Lung, Breast and Colon Cancer Cells
Cancer Cell International - United Kingdom
doi 10.1186/s12935-020-01198-8
Full Text
Open PDFAbstract
Available in full text
Date
April 16, 2020
Authors
Publisher
Springer Science and Business Media LLC